Please select the option that best describes you:
What is your preferred regimen for triple positive breast cancer with bone only recurrence?
Would you consider using ckd inhibitors in triple positive breast cancer previously treated with chemotherapy, endocrine therapy, and Herceptin? NCCN guidelines recommend hormone blocking agents only and CKD inhibitors are not approved for her2 positive disease.
Answer from: Medical Oncologist at Academic Institution
The primary options for triple positive MBC is whether to use antiestrogen approaches alone or with antiHER2 therapy, versus chemotherapy + HP. Indolent disease with bone-only involvement is the group for which antiestrogen-based approaches alone could be considered, although two randomized studies ...
Sign in or Register to read more